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Research pertaining to the neglected tropical diseases (NTDs) poses specific challenges that are
linked to the diseases investigated, infrastructure (or lack thereof), culture, social-ecological
systems, conflicting health policies, and ethics requirements, among others [1–3]. In 2010, the
European research network on better diagnosis for neglected infectious diseases (NIDIAG con-
sortium; see: http://www.nidiag.org) was launched to carry out collaborative research with an
emphasis on NTDs. NIDIAG’s overarching goal was to generate evidence about the spectrum
of causal pathogens of selected syndromes in different epidemiologic settings in order to
improve the diagnosis and management.
The NIDIAG consortium is composed of research groups from African and Asian countries
endemic for human African trypanosomiasis, schistosomiasis, soil-transmitted helminthiasis,
visceral leishmaniasis (VL), and other NTDs, together with European biomedical and clinical
researchers working on the same topics. The research is facilitated by a grant from the Euro-
pean Union (EU) within the Seventh Framework Programme (FP7). The consortium launched
its work on November 1, 2010, for an initial five-year period and an additional six-month no-
cost extension until April 30, 2016.
In the current issue of PLoS Neglected Tropical Diseases, a collection of articles [4–8, 39]—
mainly prepared in the style of symposia—is published, in which we would like to share experi-
ences and lessons from the NIDIAG consortium that range from designing, setting up, imple-
menting, and evaluating multiple clinical studies in partner countries in the global South. In
this editorial, we provide an umbrella, discuss perceived challenges in the field of NTD
research, and propose solutions on how these issues were overcome during the conduct of the
NIDIAG studies. We hope that this article collectionwill stimulate others working on clinical-
diagnostic issues of NTDs to further improve patient management and population-based con-
trol and elimination.
Challenge #1: Binary Thinking and Syndromic Management of
NTDs
NTDs have often been discussed from an exclusive pathogen or “single disease” perspective
rather than considering the potential etiologies of specific clinical syndromes with which a
patient presents to a health care center. Additionally, a distinctionwas made between those
NTDs that are thought to be controllable at the population level by means of mass drug admin-
istration (e.g., five to six rounds of albendazole plus ivermectin administered to all community
members aged five years and above against lymphatic filariasis) and preventive chemotherapy
(e.g., annual treatment of school-aged children with praziquantel against schistosomiasis) on
one hand, and, on the other hand, those NTDs that involve individual case finding and
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management (e.g., Buruli ulcer) [9]. Recently, increasing attention has been given to the issues
of co-endemicity, coinfection, and comorbidity [10–12], but generally, binary thinking prevails
with regard to the identification,management, control, and elimination of NTDs. It should be
noted, however, that for the patients suffering from those problems, the specific causal patho-
gens are of lesser importance. It is the backache, headache, and persistent diarrhea that prevent
rural dwellers from working their land, the threat to lose their children to a fatal febrile illness,
and the intractable scar in a young daughter’s face that may isolate her socially for the remain-
der of her life. These are some of the genuine problems of NTDs from the patient’s perspective.
Suppose your child has been feverish for more than two weeks, but you are sent back home
from the primary health care center without a treatment because the rapid diagnostic tests
(RDTs) for malaria and VL done at the center were negative: that is profoundly unsatisfactory
for any parent or caregiver. This issue is far from being resolved. The full extent and the chang-
ing patterns of the “non-malarial fever” have been acknowledged by the global health commu-
nity only recently [13,14]. Although fevers due to causes other than malaria have been
investigated by researchers for decades [15,16], the actual, true burden has not been fully
appreciated until the introduction of highly sensitive RDTs and their broad application even in
remote health care centers in endemic settings [17]. Indeed, malaria is now ruled out in a large
number of patients with febrile syndromes in tropical regions, and, immediately, a large spec-
trum of possible differential diagnoses unfolds [15,18–20]. However, even in the case of labora-
tory-confirmeddetection of a pathogen in a patient specimen, recent research has brought to
light that the attribution of causation remains daunting [21,22].
Unfortunately, the laboratories in resource-constrained settings are often not able to give
guidance for therapeutic management. In practice, patients usually receive a cocktail of drugs,
including antibiotics, on an empiric basis, and they are told to come back if they do not get bet-
ter [17]. Syndromic management is probably a better approach in such cases, as has been
shown for sexually transmitted infections [23] and integrated management of childhood illness
[24]. However, it has also been demonstrated that these syndromic guidelines are frequently
not being followed in endemic areas, in particular if the health care personnel do not receive
specific training pertaining to these guidelines and are not involved in the process of develop-
ing such guidance tools [25]. Thus far, the evidence base for a syndromic approach toward
common clinical syndromes in areas characterized by a high prevalence of specificNTDs is
flimsy at best. It is important to note that clinical syndromes are defined by a frequently
encountered combination of clinical signs and symptoms, such as long-lasting fever, abdomi-
nal complaints, or respiratory signs suggestive of infection, and not by a specific etiology.
Hence, a “syndromic approach to NTDs” pertains to clinical syndromes that occur frequently
in tropical and subtropical areas and where it may be anticipated that a large proportion of
these diseases are caused by NTDs. Indeed, when a patient with a given clinical symptomatol-
ogy presents to a rural health care center, binary diagnosis-treatment strategies are commonly
employed, which frequently focus on ruling in or out a specific disease, whereas other causes of
a similar symptomatology are not sufficiently considered in existing algorithms. An example of
such a strategy is shown in Fig 1, i.e., a recommended algorithm for the diagnosis of VL (also
known as kala-azar) in endemic areas. Such inflexible “yes/no algorithms” are often of limited
value to clinicians working in settings where multiple NTDs and other infections coexist.
Hence, the NIDIAG consortium set out to employ a syndromic approach to elucidate the dif-
ferential diagnosis of three NTD-related syndromes, namely (i) persistent fever [26,27]; (ii)
neurological disorders [28]; and (iii) persistent digestive disorders [29,30].
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Challenge #2: Implementing Research Compliant with Good
Clinical Practice (GCP) and Good Clinical Laboratory Practice
(GCLP)
The idea for the syndrome-specificNIDIAG investigations was straightforward: design and
implement a series of prospective clinical studies, recruit patients with one of the three syn-
dromes at primary care level in NTD-endemic areas, and try to reach a final diagnosis in the
greatest possible number, if necessary, through the shipment of samples to reference laborato-
ries in-country or abroad. The knowledge on specific pathogens causing the pre-specified syn-
drome could then be used in a second stage to elaborate clinical-diagnostic algorithms and to
provide guidance for a given epidemiologic setting.
Yet, a seemingly straightforward idea can become complex, particularly when the ambition
is to employ a syndromic approach, to work in multiple study sites, to be compliant with the
essential ethical principles of respect for persons, beneficence, and justice [31], and to adhere to
good clinical practice (GCP) and good clinical laboratory practice (GCLP) standards through-
out. Needless to say that the challenges are plentiful; that they are of scientific, ethical, legal,
regulatory, and logistic nature; and that they are complex in today’s scenario of international
research [32]. Indeed, clinical research conducted in resource-constrained settings has to come
to grips with essential challenges related to community engagement, participants’ vulnerability,
upgrade of local clinical and laboratory infrastructures, data sharing, sample storage and
Fig 1. Binary algorithm for the diagnostic evaluation of visceral leishmaniasis (VL, also known as kala-
azar) in South Asia. Investigations for alternative pathogens that may give rise to a similar clinical syndrome are
not considered in such an algorithm.
doi:10.1371/journal.pntd.0004853.g001
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shipment abroad, capacity transfer, and benefit sharing. For instance, a recent systematic
review has underscored that there is considerable heterogeneity across sub-Saharan Africa
regarding biobanking issues, with often conflicting regulations and guidelines in different
countries, which are likely to negatively affect international collaborative efforts [33]. Addition-
ally, the harmonization of diagnostic and clinical procedures in multi-country studies is fre-
quently not sufficiently addressed and, particularly in low- and middle-income countries,
training and adherence to GCP/GCLP guidelines is particularly challenging [34].
With regard to diagnostic accuracy, core requirements are the establishment of a quality
assurance system that includes internal and external quality control and monitoring activities
[35]. This is an important prerequisite to avoid misleading research results, as has recently
been underscored by a nationwide study from the Democratic Republic of the Congo, where
more than 60% of laboratories failed to reach an acceptable score for the microscopic diagnosis
of malaria and human African trypanosomiasis [36]. The study also demonstrated better
results at sites where regular training and external quality assessments were carried out.
Hence, a legacy of the NIDIAG consortium is the efforts made with harmonizing study
protocols and the development and validation of a large number of standard operating pro-
cedures (SOPs) that were employed in the context of this project. Indeed, 80 specific SOPs
were developed by the NIDIAG consortium,mainly in the domains of laboratory (n = 59),
data management, documentation, quality control (n = 13), and clinical aspects (n = 8). A
summary of all the SOPs, stratified by syndrome, is given below (Table 1). As can be seen,
many SOPs were used across syndromes, which demonstrates harmonization of quality sys-
tems beyond specific boundaries. Other SOPs are disease- and syndrome-specific,which is to
be expected, as the diagnosis, management, and treatment are idiosyncratic.We believe that
sharing these SOPs on an open-access platform and providing additional specific informa-
tion in a set of symposia articles in the current issue of PLoS Neglected Tropical Diseases [4–
8] will contribute to facilitate and further strengthen GCP/GCLP-compliant clinical research
by colleagues working in this field. Here, we share experiences and lessons from the NIDIAG
consortium that range from designing, setting up, implementing, and evaluating multiple
GCP/GCLP-compliant clinical studies in low- and middle-income countries in Africa and
Asia. Hence, it is our hope that the various SOPs will be used, adapted to specific local con-
texts, and further improved in the interest of the most neglected patients—those living in
NTD-affected areas.
Challenge #3: Maintaining Improved Patient Care after Clinical
Studies Have Come to an End
Not only the scientific findings of a clinical study, but also the study procedures and the learn-
ing process during the conduct of the study can contribute to improved patient care afterwards.
SOPs that are developed in the first place to define and harmonize procedures (across opera-
tors, sites, and countries) within a specific clinical study could also be beneficial after the end of
that study, because they might be used as practical training tools, and they might help achiev-
ing sustained improvement of clinical and diagnostic procedures. Nevertheless, there are many
barriers for the consistent use of SOPs. During the course of a study, these include the fear that
clinical autonomy will be reduced, underestimating the importance of harmonization of clini-
cal and laboratory procedures, the fear that written guidelines will cause additional paperwork,
lack of a culture of quality assurance systems, and lack of motivation to change practice [37].
After the end of a clinical study, and particularly in resource-constrained settings, there is a
risk that quality improvements achieved during the study will erode when staff support, incen-
tives, means, and monitoring suddenly come to an end [38].
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Table 1. Overview of SOPs for the three syndromes addressed in the NIDIAG consortium.
Type of SOP Purpose of SOP Intended user Use in NIDIAG syndromes
Persistent
fever
Neurological
disorders
Persistent
digestive
disorders
Clinical Assessing inclusion / exclusion criteria Site investigators p p p
Clinical History taking Site investigators – – p
Clinical Clinical examination (at baseline and during follow-
up)
Site investigators p p p
Clinical Selection of controls Site investigators – – p
Clinical Clinical management of patients Site investigators – p p
Clinical Patient recruitment and patient flow Site investigators – – p
Clinical Performing lumbar puncture Site investigators p p
Clinical Performing bone marrow aspirate Site investigators p – –
Laboratory Diagnostic sample flow All research staff p p p
Laboratory Urine sampling Study nurses p p p
Laboratory Blood sampling (blood cultures, serum, heparin, and
EDTA whole blood)
Study nurses p p –
Laboratory How to obtain a stool sample Site investigator and study
nurses
– –
p
Laboratory Lymph node aspiration Study nurses p p –
Laboratory Hemoglobin measurement with HemoCue Hb 301 Laboratory technicians p p –
Laboratory White blood cell count and differentiation with
HemoCue WBC DIFF
Laboratory technicians p p –
Laboratory Thick blood film, Giemsa staining, and microscopic
examination
Laboratory technicians p p –
Laboratory White blood cell count in CSF with counting chamber
"Uriglass" (Menarini)
Laboratory technicians – p –
Laboratory Gram staining of CSF samples Laboratory technicians – p –
Laboratory Leukocyte differentiation on a Giemsa-stained CSF
smear
Laboratory technicians – p –
Laboratory Use of the Reflotron Plus (Roche) biochemical
analyzer
Laboratory technicians p p –
Laboratory Glucose test (glycaemia)—HumaSens glucometer Laboratory technicians – p –
Laboratory CSF culture in trans-isolate (T-I) medium Laboratory technicians – p –
Laboratory CSF culture in pediatric Bact/Alert bottles Laboratory technicians – p –
Laboratory CD4+ cell count (Dynal T4 Quant Kit/Invitrogen) Laboratory technicians – p –
Laboratory Storage of bacterial isolates Laboratory technicians p – –
Laboratory Use of urine test strips «Multistix 10 SG» (Siemens
Healthcare Diagnostics)
Laboratory technicians p – –
Laboratory Direct fecal smear technique Laboratory technicians – – p
Laboratory Preparation of aliquots for molecular testing Laboratory technicians – – p
Laboratory Fresh trypanosome examination in lymph node fluid Laboratory technicians – p –
Laboratory Mini anion exchange centrifugation technique
(mAECT)
Laboratory technicians p p –
Laboratory Modified single centrifugation Laboratory technicians p p –
Laboratory Capillary tube centrifugation technique Laboratory technicians p p –
Laboratory
(index test)
Card agglutination test for Trypanosoma brucei
gambiense (CATT/T.b. gambiense)
Laboratory technicians p p –
Laboratory
(index test)
Performing the SD Bioline HAT test (Standard
Diagnostics)
Laboratory technicians p p –
Laboratory
(index test)
Performing the Gambiense HAT Sero-K-Set test
(Coris BioConcept)
Laboratory technicians p p –
(Continued )
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Table 1. (Continued)
Type of SOP Purpose of SOP Intended user Use in NIDIAG syndromes
Persistent
fever
Neurological
disorders
Persistent
digestive
disorders
Laboratory CareStart Malaria pLDH (Access Bio) Laboratory technicians p p –
Laboratory Malaria SD BIOLINE Ag Pf/Pan (SD 05FK60) Laboratory technicians p p –
Laboratory Performing the DAT Laboratory technicians p – –
Laboratory Inoculating and growing cultures of Leishmania
donovani from body fluids and tissue aspirates
Laboratory technicians p – –
Laboratory Detecting L. donovani in body fluids and tissue
aspirates
Laboratory technicians p – –
Laboratory
(index test)
Performing the rK28 from EASE-Medtrend Laboratory technicians p – –
Laboratory
(index test)
Performing the rK39 IT LEISH (Bio-Rad) Laboratory technicians p – –
Laboratory
(index test)
Performing the Salmonella Typhi IgM/IgG (SD
Bioline)
Laboratory technicians p – –
Laboratory
(index test)
Performing the Typhidot Rapid IgM (Reszon
Diagnostics)
Laboratory technicians p – –
Laboratory
(index test)
Performing the Test-it Typhoid IgM (Life Assay) Laboratory technicians p – –
Laboratory
(index test)
Performing the Leptospira IgG/IgM (SD Bioline) Laboratory technicians p – –
Laboratory
(index test)
Performing the Test-it Leptospirosis IgM (Life Assay) Laboratory technicians p – –
Laboratory Syphilis–RPR test on Macro-Vue cards Laboratory technicians – p –
Laboratory
(index test)
SD Bioline Syphilis 3.0 (Standard Diagnostics) Laboratory technicians – p –
Laboratory India ink staining for Cryptococcus in CSF Laboratory technicians – p –
Laboratory Cryptococcus antigen latex agglutination test Laboratory technicians – p –
Laboratory
(index test)
Cryptococcus Antigen (CrAg) Lateral Flow Assay
(Immunomycologics)
Laboratory technicians – p –
Laboratory Determine HIV-1/2 Laboratory technicians p p –
Laboratory Uni-Gold HIV Laboratory technicians – p –
Laboratory DoubleCheckGold HIV 1&2 Laboratory technicians – p –
Laboratory CSF culture for mycobacteria in BBL MGIT medium
(BD) supplemented with OADC and PANTA
Laboratory technicians – p –
Laboratory Hot Ziehl-Neelsen staining for detection of
mycobacteria in CSF
Laboratory technicians – p –
Laboratory Sputum collection, smear and hot Ziehl-Neelsen
staining for detection of mycobacteria
Laboratory technicians p p –
Laboratory Kato-Katz technique Laboratory technicians – – p
Laboratory Mini-FLOTAC technique Laboratory technicians – – p
Laboratory Formalin-ether concentration technique Laboratory technicians – – p
Laboratory Kinyoun staining technique Laboratory technicians – – p
Laboratory Modified acid-fast staining technique Laboratory technicians – – p
Laboratory Koga agar plate culture Laboratory technicians – – p
Laboratory Baermann technique Laboratory technicians – – p
Laboratory
(index test)
Crypto-Giardia Duo-Strip (Coris BioConcept) rapid
diagnostic test
Laboratory technicians – – p
(Continued )
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Ownership and local leadership is paramount for sustained adherence to a quality system.
Within the NIDIAG project, we have tried to contribute to the long-term sustainability of the
quality system in the following ways: by doing the diagnostic testing as much as possible in the
study sites; by investing in the training and remote support of local staff; by jointly developing
SOPs that are readily adapted to specific contexts thanks to the input of local staff; and by
transferring equipment to the study sites at the end of the study and ensuring sustained assis-
tance for its maintenance. Although in the beginning, there was quite some skepticism from
some staff regarding the introduction of a quality system based on GCP/GCLP and SOPs, the
moodwas very different at the end of the NIDIAG project. In the final consortiummeeting
done in March 2016 in Indonesia, several researchers spontaneously mentioned that getting to
know GCP/GCLP in practice and engaging in a dialoguewith study monitors and laboratory
supervisors had been an enriching experience and assisted in building up local research capac-
ity, which will facilitate further research and improved clinical-diagnosticmanagement of
NTDs in the global South.
Conclusion
By sharing our experiences and lessons with GCP/GCLP-compliant clinical research in NTD-
endemic settings and providing open access to a host of SOPs jointly developed during the
NIDIAG project, we hope to help other researchers to overcome some of the specific challenges
Table 1. (Continued)
Type of SOP Purpose of SOP Intended user Use in NIDIAG syndromes
Persistent
fever
Neurological
disorders
Persistent
digestive
disorders
Laboratory
(index test)
Point-of-care circulating cathodic antigen
(POC-CCA) urine cassette test for the diagnosis of
Schistosoma mansoni
Laboratory technicians – – p
Document Obtaining informed consent Site investigators p p p
Document Patients and samples numbering system in NIDIAG
studies
All research staff p p p
Document Management of study documents All research staff p p p
Quality SOP on SOP SOP authors and
reviewers
p p p
Quality Internal quality control activities All research staff p p p
Quality External monitoring All research staff p p p
Quality Laboratory monitoring Site investigators;
laboratory technicians;
monitors
p p p
Quality Min/max thermometer Laboratory technicians p p p
Quality Stock management Laboratory technicians p p p
Quality Handling of expired and disqualified products Laboratory technicians p p p
Quality Handling and storage of RDTs Laboratory technicians p p p
Data Completing case report forms (CRFs) Site investigators p p –
Data Data management Data entry clerks p – p
Ag: antigen; CRF: case report form; CSF: cerebrospinal fluid; DAT: direct agglutination test; EDTA: ethylenediaminetetraacetic acid; HAT: human African
trypanosomiasis; Ig: immunoglobin; IT: immunochromatographic test; LDH: lactate dehydrogenase; RDT: rapid diagnostic test; SOP: standard operating
procedure; RPR: rapid plasma reagin
doi:10.1371/journal.pntd.0004853.t001
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related to NTD research. In turn, we are confident that this will contribute to a culture of qual-
ity clinical research in NTD-endemic countries.
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